Fundraising advisory for healthcare startups

In healthcare, innovation isn't enough; you need capital, compliance, and credibility

Whether you're developing a new medical device, scaling a digital health platform, or bringing biotech research to market, investors expect rigor.

At dups, we help healthcare startups raise capital smarter, faster, and safer. Our integrated legal and financial team structures your fundraising so you can focus on science, not on the paperwork.

Why healthcare fundraising is different

Raising capital in healthcare involves more than valuation and traction. Investors scrutinize regulatory pathways and clinical milestones, intellectual property ownership, capital efficiency and burn rate, and team credibility and scientific advisory board.

And yet, deals still need to move at startup speed. We combine sector understanding with deal pragmatism, making sure your fundraising is both compliant and competitive.

Our healthcare fundraising approach

1. Readiness and strategic structuring

We start by clarifying your funding story: clinical or regulatory roadmap, IP ownership and licensing structure, capital needs vs. milestone timeline, and investor targeting (VCs, CVCs, impact funds, family offices).

We translate your science into a financial and legal narrative investors trust.

2. Financial modeling and valuation

We design valuation frameworks that reflect both scientific progress and commercial potential: scenario-based valuation (preclinical, clinical, market-ready), convertible or milestone-based funding models, and option pools for scientific co-founders and key hires.

Our models help you raise what you need without over-diluting early.

3. Legal structuring and documentation

Our legal team drafts and negotiates term sheets and investment agreements, shareholders' agreements (SHA), IP licensing and assignment clauses, and convertible notes or SAFE tailored to R&D stages.

All aligned with healthtech and biotech investor expectations: compliant, clear, and scalable internationally.

4. Investor engagement and closing

We guide you through the investor journey: investor deck and memo preparation, due diligence preparation (IP, regulatory, financials), negotiation of rights, milestones, and governance, and closing and post-closing coordination.

We ensure your capital inflow matches your clinical and market milestones, not investor bureaucracy.

Healthcare segments we support

Medtech and medical devices

Prototype to market transition funding, CE/FDA regulatory alignment, and IP structuring and partner agreements.

Biotech and life sciences

Seed or Series A capital for R&D and trials, licensing or co-development partnerships, and IP assignment and royalty structuring.

Digital health and eHealth

SaaS and data compliance structuring (GDPR, HIPAA), subscription-based valuation models, and cross-border investment documentation.

What makes dups different

Sector fluency: we understand healthcare deals (regulatory, IP-heavy, and milestone-based).

Integrated execution: legal and financial teams work together from the first draft to final closing.

Investor alignment: we speak both "founder" and "VC"; we translate science into deal logic investors understand.

Cross-border expertise: we work with EU, UK, and US investors familiar with healthcare growth models and regulations.

Deliverables you can expect

We deliver a complete, healthcare-specific fundraising package:

• Investor readiness report (healthcare-specific)
• Valuation and milestone modeling
• Term sheet and SHA drafting or negotiation
• IP ownership and licensing structure review
• Due diligence preparation and closing coordination

Each deliverable is adapted to your maturity, IP complexity, and regulatory stage.